Accelerator Launched To Advance Digital Innovations And Collaboration In Oncology Industry Trends Gaining Momentum in the Global Adrenal Cancer Diagnostics Market

"Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.

Adrenal Cancer Diagnostics Market Size Valuation Forecast: What Will the Market Be Worth by 2025?
In recent times, there has been a significant expansion in the market size of adrenal cancer diagnostics. The market, currently valued at $140.35 billion in 2024, is projected to increase to $149.96 billion by 2025, with a compound annual growth rate (CAGR) of 6.8%. The market's historic growth trajectory is credited to several factors, including a rise in occurrence and awareness, advancements in genetic and molecular testing, enhanced biopsy protocols, improved endocrine testing and the integration of artificial intelligence (AI).

Adrenal Cancer Diagnostics Market Size Forecast: What's the Projected Valuation by 2029?
The market size for diagnosing adrenal cancer is predicted to show significant expansion in the upcoming years, with an expected valuation of $193.26 billion in 2029, growing at a Compound Annual Growth Rate (CAGR) of 6.5%. The escalation in the forecast period can be linked to the adoption of personalized medical treatments, the surge in minimally invasive medical procedures, advancements in telemedicine and remote consultations, the progress of liquid biopsy, and growing genetic counseling services. Key emerging trends expected during this period reflect regulatory backing for innovative diagnostic technologies, the integration of digital pathology, the enhancement of imaging technologies, the progress of liquid biopsy, and the application of genomic profiling in precision medicine.

View the full report here:
https://www.thebusinessresearchcompany.com/report/adrenal-cancer-diagnostics-global-market-report

What Are the Drivers Transforming the Adrenal Cancer Diagnostics Market?
The expected increase in cigarette smoking is anticipated to boost the growth of the adrenal cancer diagnostics market. The activity of smoking cigarettes, which involves inhaling and exhaling tobacco smoke containing nicotine, an addictive alkaloid with psychoactive properties, is related to this trend. A proven connection has been established between cigarette smoking and an increased risk of adrenal cancer, including adrenal adenomas and adrenocortical carcinomas. The carcinogenic substances found in tobacco smoke are known to cause DNA damage in adrenal cells, leading to mutations that may result in cancer. For example, Statistics Canada reported in July 2022 that cigarette production saw a rise of 5.8% compared to June 2021. There was also an increase in the total number of cigarettes sold by 1.3% from May 2022, hitting 1.4 billion in June 2022. As a result, the increase in cigarette smoking is fuelling the expansion of the adrenal cancer diagnostics market. The significant role played by government initiatives to support cancer is key in driving the growth of the adrenal cancer diagnostics market in the future. These initiatives represent a substantial increase in action by governments to tackle and alleviate various challenges, issues, or crises. These efforts play a crucial role in promoting early diagnosis, improving the quality and accessibility of diagnostic services, supporting research, and ultimately increasing the efficiency of adrenal cancer diagnostics. An example of this is the initiative established by the Biden-Harris administration in April 2023, as reported by the NIH (National Institutes of Health), a US-based government agency responsible for biomedical and public health research. This endeavor aims to reduce cancer-related fatalities by 50% over the next 25 years, as well as increase understanding and support for those living with and surviving cancer. Consequently, government initiatives to support cancer are driving the future growth of the adrenal cancer diagnostics market.

Get your free sample here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=13242&type=smp

What Long-Term Trends Will Define the Future of the Adrenal Cancer Diagnostics Market?
Leading businesses in the adrenal cancer diagnostics market are pioneering new approaches through progressive partnership models, such as the CancerX Startup Accelerator, to amplify digital advancements in cancer treatment. The Accelerator is designed to equip emerging startups with mentorship, education, and a direct link to major participants in the healthcare sector, including service providers and pharmaceutical corporations. For example, in November 2023, CanceRx, LLC, a public-private alliance based in the US for driving innovation in cancer battle, unveiled this initiative at the Future of Cancer Care Summit in Tampa, Florida. The program plans to enlist its first group of approximately 15 to 20 companies in March 2024, concentrating on key areas such as clinical studies, screening, diagnosis, and therapy. This is anticipated to considerably progress the objectives of the Cancer Moonshot initiative by addressing the gaps in cancer care and encouraging the creation of efficient digital health tools in oncology.

Which Segments in the Adrenal Cancer Diagnostics Market Offer the Most Profit Potential?
The adrenal cancer diagnostics market covered in this report is segmented -

1) By Test: Magnetic Resonance Imaging (MRI), Computed Tomography (CT) Scan, X-ray, Positron Emission Tomography (PET) Scan, Biopsy
2) By Treatment: Surgery, Chemotherapy, Radiotherapy, Targeted Cancer Therapies, Other Treatments
3) By Tumor Type: Pheochromocytoma, Adrenal Cortical Carcinoma, Other Types
4) By End-User: Hospitals, Ambulatory Surgical Centers, Cancer Centers, Other End-Users

Subsegments:
1) By Magnetic Resonance Imaging (MRI): Contrast-Enhanced MRI, Functional MRI
2) By Computed Tomography (CT) Scan: Contrast-Enhanced CT, Abdomen And Pelvis CT Scans
3) By X-ray: Standard X-ray Imaging, Specialized X-ray Techniques
4) By Positron Emission Tomography (PET) Scan: PET-CT Combination Scans, Standalone PET Scans
5) By Biopsy: Fine Needle Aspiration Biopsy (FNA), Core Needle Biopsy, Surgical Biopsy

Tailor your insights and customize the full report here:
https://www.thebusinessresearchcompany.com/customise?id=13242&type=smp

Which Firms Dominate the Adrenal Cancer Diagnostics Market by Market Share and Revenue in 2025?
Major companies operating in the adrenal cancer diagnostics market report are Johnson And Johnson Pvt Ltd., F. Hoffmann-La Roche Ltd., Thermo Fisher Scientific, GSK PLC, AstraZeneca PLC, Abbott Laboratories, Siemens Healthcare GmbH, Becton Dickinson and Company, Koninklijke Philips N.V., GE HealthCare Technologies Inc., Agilent Technologies, Hologic Inc., PerkinElmer Inc., Illumina Inc., Roche Diagnostics, BioMerieux SA, Sysmex Corporation, Bio-Rad Laboratories Inc., Bruker Corporation, Exact Sciences Corp., Natera Inc., Invitae Corporation, Qiagen NV, Guardant Health Inc., Foundation Medicine Inc., NanoString Technologies Inc., TRS Technologies Inc., Morgan Advanced Materials, APC International Ltd., Annon Piezo Technology Co. Limited

Which Regions Offer the Highest Growth Potential in the Adrenal Cancer Diagnostics Market?
North America was the largest region in the adrenal cancer diagnostics market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the adrenal cancer diagnostics market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

Purchase the full report today:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=13242

This Report Supports:
1. Business Leaders & Investors - To identify growth opportunities, assess risks, and guide strategic decisions.
2. Manufacturers & Suppliers - To understand market trends, customer demand, and competitive positioning.
3. Policy Makers & Regulators - To track industry developments and align regulatory frameworks.
4. Consultants & Analysts - To support market entry, expansion strategies, and client advisory work.

Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: info@tbrc.info

Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ"

Learn More About The Business Research Company
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead.
Our flagship product, the Global Market Model (GMM), is a premier market intelligence platform delivering comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.